Expression of p14ARF, p15INK4b, p16INK4a, and DCR2 increases during prostate cancer progression

[1]  Zhaohui Lu,et al.  Adenovirus-mediated Ink4a/ARF gene transfer significantly suppressed the growth of pancreatic carcinoma cells , 2005, Cancer biology & therapy.

[2]  F. Khuri,et al.  Decoy receptor 2 (DcR2) is a p53 target gene and regulates chemosensitivity. , 2005, Cancer research.

[3]  J. Shay,et al.  BRAFE600-associated senescence-like cell cycle arrest of human naevi , 2005, Nature.

[4]  M. Barbacid,et al.  Tumour biology: Senescence in premalignant tumours , 2005, Nature.

[5]  P. di Sant'Agnese,et al.  Tumorigenesis and Neoplastic Progression Differential Expression of Interleukin-8 and Its Receptors in the Neuroendocrine and Non-Neuroendocrine Compartments of Prostate Cancer , 2005 .

[6]  Stephen Neidle,et al.  A G-quadruplex telomere targeting agent produces p16-associated senescence and chromosomal fusions in human prostate cancer cells. , 2004, Molecular cancer therapeutics.

[7]  A. Ashkenazi,et al.  Targeting death receptors in cancer with Apo2L/TRAIL. , 2004, Current opinion in pharmacology.

[8]  S. Toyooka,et al.  Aberrant methylation of trail decoy receptor genes is frequent in multiple tumor types , 2004, International journal of cancer.

[9]  H. Chung,et al.  Modulation of redox-sensitive transcription factors by calorie restriction during aging , 2002, Mechanisms of Ageing and Development.

[10]  Yan Shi,et al.  Role of cyclin-dependent kinase inhibitors in the growth arrest at senescence in human prostate epithelial and uroepithelial cells , 2001, Oncogene.

[11]  J. Slingerland,et al.  Reduction of Cdc25A contributes to cyclin E1-Cdk2 inhibition at senescence in human mammary epithelial cells , 2000, Oncogene.

[12]  Hoguen Kim,et al.  p16 is a major inactivation target in hepatocellular carcinoma , 2000, Cancer.

[13]  M. Benson,et al.  Expression of senescence-associated beta-galactosidase in enlarged prostates from men with benign prostatic hyperplasia. , 2000, Urology.

[14]  Tudung T Nguyen,et al.  Analysis of cyclin‐dependent kinase inhibitor expression and methylation patterns in human prostate cancers , 2000, The Prostate.

[15]  A. Fornace,et al.  The TRAIL decoy receptor TRUNDD (DcR2, TRAIL-R4) is induced by adenovirus-p53 overexpression and can delay TRAIL-, p53-, and KILLER/DR5-dependent colon cancer apoptosis. , 2000, Molecular therapy : the journal of the American Society of Gene Therapy.

[16]  M. Newton,et al.  p16/pRb pathway alterations are required for bypassing senescence in human prostate epithelial cells. , 1999, Cancer research.

[17]  V. Dixit,et al.  Death receptors: signaling and modulation. , 1998, Science.

[18]  D. Haber,et al.  Splicing into Senescence: The Curious Case of p16 and p19ARF , 1997, Cell.

[19]  Richard A. Ashmun,et al.  Tumor Suppression at the Mouse INK4a Locus Mediated by the Alternative Reading Frame Product p19 ARF , 1997, Cell.

[20]  C. Sherr.  Cancer Cell Cycles , 1996, Science.

[21]  C. Reznikoff,et al.  Elevated p16 at senescence and loss of p16 at immortalization in human papillomavirus 16 E6, but not E7, transformed human uroepithelial cells. , 1996, Cancer research.

[22]  G. Peters,et al.  Regulation of p16CDKN2 expression and its implications for cell immortalization and senescence , 1996, Molecular and cellular biology.

[23]  F. Zindy,et al.  Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest , 1995, Cell.

[24]  Gregory J. Hannon,et al.  pl5INK4B is a potentia| effector of TGF-β-induced cell cycle arrest , 1994, Nature.

[25]  L. Hayflick,et al.  The serial cultivation of human diploid cell strains. , 1961, Experimental cell research.

[26]  Taylor Murray,et al.  Cancer Statistics, 2001 , 2001, CA: a cancer journal for clinicians.

[27]  G. Hannon,et al.  p15INK4B is a potential effector of TGF-beta-induced cell cycle arrest. , 1994, Nature.